Innovating CNS Disease Modeling: Tailoring Cells & Editing Genomes

Originally aired on March 26, 2020 

Evolving in vitro models provide powerful platforms to unravel disease mechanisms and translate this knowledge to useful therapeutics. This Cell Press Webinar will focus on the application of recent genomic and cellular engineering technologies, including CRISPR and organoids, to model neurological indications.

In this webinar, you'll hear from three leaders in the field: Kristen Brennand (Icahn School of Medicine at Mount Sinai), Stanley Qi (Stanford University), and Madeline Lancaster (MRC Laboratory of Molecular Biology). Each will present work done in their labs that enables the development of in vitro cellular platforms from healthy individuals and patients, and elaborate on the results of their investigations.

Kristen Brennand
Associate Professor
Department of Genetics and Genomic Sciences,
Nash Family Department of Neuroscience,
Department of Psychiatry,
Icahn School of Medicine at Mount Sinai
View Biography
Stanley Qi
Assistant Professor
Department of Bioengineering
Department of Chemical and Systems Biology
Stanford ChEM-H
Stanford University
View Biography
Madeline Lancaster
Principal Investigator,
MRC Laboratory of Molecular Biology, UK
View Biography
Moderator: Prithi Rajan
Scientific Editor
Cell Stem Cell

Registration Details:

Our registration process uses cookies, by submitting this registration form you agree to our cookie policy.

(*) denotes required form field(s)